837334

CCB-MCB LLC — FEI 3006199266

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 2, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1227821 CFR 1271.75(a)(2)Risks associated with xenotransplantation